Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
FDA issues updated recommendations concerning dental amalgam

FDA issues updated recommendations concerning dental amalgam

NIA grant supports research on lifespan behavioral development and cognitive aging

NIA grant supports research on lifespan behavioral development and cognitive aging

Research sheds light on how membrane proteins could be influenced by lipid environments

Research sheds light on how membrane proteins could be influenced by lipid environments

Magnetic resonance spectroscopy helps distinguish brain energy molecules

Magnetic resonance spectroscopy helps distinguish brain energy molecules

Overactivation of fructose made in the brain may drive Alzheimer's disease

Overactivation of fructose made in the brain may drive Alzheimer's disease

Dextran sulphate-induced tau assemblies cause tau propagation in non-transgenic mice

Dextran sulphate-induced tau assemblies cause tau propagation in non-transgenic mice

Late-life depression not linked with increased amyloid deposits in the brain

Late-life depression not linked with increased amyloid deposits in the brain

Intensive physical exercise session improves memory

Intensive physical exercise session improves memory

Drugs used to treat HIV and hepatitis B could be repurposed to prevent type 2 diabetes

Drugs used to treat HIV and hepatitis B could be repurposed to prevent type 2 diabetes

Three question, yes-or-no survey for identifying chemically intolerant individuals

Three question, yes-or-no survey for identifying chemically intolerant individuals

New national research and training hub at UW-Madison could transform medicine

New national research and training hub at UW-Madison could transform medicine

Biomarker for earlier diagnosis of neurodegenerative diseases detected in the eye

Biomarker for earlier diagnosis of neurodegenerative diseases detected in the eye

California’s deadliest spring in 20 years suggests COVID undercount

California’s deadliest spring in 20 years suggests COVID undercount

Astrocytes are essential for blood-brain barrier health, shows study

Astrocytes are essential for blood-brain barrier health, shows study

Research identifies new alteration in the brain of people with Alzheimer's

Research identifies new alteration in the brain of people with Alzheimer's

Actively speaking two languages delays the onset of mild cognitive impairment

Actively speaking two languages delays the onset of mild cognitive impairment

Molecular imaging probe reveals Alzheimer's-related γ-secretase in rodents, macaques

Molecular imaging probe reveals Alzheimer's-related γ-secretase in rodents, macaques

Women with prolonged fertility have elevated dementia risk

Women with prolonged fertility have elevated dementia risk

Smart drug delivery system may help treat spinal cord injuries, neurological disorders

Smart drug delivery system may help treat spinal cord injuries, neurological disorders

Salk institute to establish world-class consortium to study cellular and tissue aging in humans

Salk institute to establish world-class consortium to study cellular and tissue aging in humans

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.